| Literature DB >> 35097302 |
Lucia Ya Zakharova1, Alexandra D Voloshina1, Marina R Ibatullina2, Elena P Zhiltsova1, Svetlana S Lukashenko1, Darya A Kuznetsova1, Marianna P Kutyreva2, Anastasiia S Sapunova1, Anna A Kufelkina1, Natalia V Kulik1, Olga Kataeva1, Kamil A Ivshin2, Aidar T Gubaidullin1, Vadim V Salnikov3, Irek R Nizameev1, Marsil K Kadirov1, Oleg G Sinyashin1.
Abstract
New 1-cetyl-4-aza-1-azoniabicyclo[2.2.2]octane bromide complexes with copper(II) bromide and lanthanum(III) nitrate were characterized using dynamic light scattering and transmission electron microscopy, with self-assembly and the morphological behavior elucidated. For the lanthanum(III) nitrate complex, the 3D crystal structure was characterized using X-ray diffractometry. These metallosurfactants were tested as antitumor agents, and a high cytotoxic effect comparable with doxorubicin was revealed against the M-HeLa and A-549 cell lines. Both complexes were 2 times more active toward the MCF-7 cell line than the breast cancer drug tamoxifen. The cytotoxic mechanism of complexes is assumed to be related to the induction of apoptosis through the mitochondrial pathway.Entities:
Year: 2022 PMID: 35097302 PMCID: PMC8793087 DOI: 10.1021/acsomega.1c06465
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1Structural formula of D16Br.
Figure 2Asymmetric part of the unit cell and La coordination in D16Br with the lanthanum(III) nitrate complex crystal.
Figure 3Fragment of the crystal packing of D16Br with the lanthanum(III) nitrate complex showing the [La(NO3)5H2O]2– anion coordination sphere.
Figure 4ORTEP view of D16Br in the crystal. Nonhydrogen atoms are represented by probability ellipsoids of thermal vibrations (p = 50%), hydrogen atoms—by spheres of arbitrary radii.
Figure 5TEM images of copper complex 1 (a,b) and lanthanum complex 2 (d,e) nanoparticles and size distribution curves for complex 1 (c) and 2 (f).
Cytotoxic Effects of Compounds 1 and 2 on the Cancer and Normal Human Cell Linesa
| IC50 (μM) | |||||
|---|---|---|---|---|---|
| cancer
line | normal
line | ||||
| compounds | M-Hela | MCF-7 | A549 | Chang liver | Wi-38 |
| 4.0 ± 0.3 | 14 ± 1.2 | 2.7 ± 0.2 | 6.0 ± 0.3 | 16 ± 0.9 | |
| 4.1 ± 0.3 | 13 ± 1.1 | 14 ± 1.3 | 5.0 ± 0.4 | 5.0 ± 0.3 | |
| doxorubicin | 3.0 ± 0.1 | 3.0 ± 0.2 | 3.0 ± 0.1 | 3.0 ± 0.1 | 1.3 ± 0.1 |
| tamoxifen | 28 ± 2.5 | 25 ± 2.2 | 42.1 ± 3.5 | 46.2 ± 3.5 | |
The experiments were repeated three times.
Data from ref (41).
Figure 6Apoptotic effects of compound 1 on M-HeLa cells.
Figure 7Histogram for the number of cells (% of total) in the early and late stages of apoptosis for the control and experimental groups. The values are presented as the mean ± SD (n = 3); (*) P < 0.01 compared to control.
Figure 8Effects on Δψm in M-HeLa cells that were treated with compound 1 at the indicated concentrations for 24 h and then analyzed by confocal laser scanning microscopy and flow cytometry after JC-10 staining. (a) Confocal laser scanning microscopy images of M-HeLa cells treated with compound 1. (b) Flow cytometry analysis of M-HeLa cells treated with 1.